The INSIG1 gene, not the INSIG2 gene, associated with coronary heart disease: tagSNPs and haplotype-based association study

Summary

Dyslipidemia, especially hypercholesterolemia, is a major risk factor of coronary heart disease (CHD). The insulin induced gene 1 (INSIG1) and insulin induced gene 2 (INSIG2) encode two proteins which mediate feedback control of cholesterol synthesis. We conducted a case-control study to investigate whether the common variants in INSIG genes were associated with CHD in Chinese Han population. Three single nucleotide polymorphisms (SNPs) of the INSIG1 gene and four SNPs of the INSIG2 gene were chosen as haplotype-tagging SNPs (htSNPs) and genotyped in 853 patients with CHD and 948 unrelated control subjects. Haplotype analysis showed that the haplotype Hap4 (TTA) of the INSIG1 gene significantly increased the risk of CHD (adjusted odds ratio [OR]1.59, 95% confidence interval [CI] 1.22–2.06,p=0.0006),while the haplotype Hap3 (TGA) significantly decreased the risk of CHD (adjusted OR 0.74, 95%CI 0.60–0.92, p=0.006) compared with the reference haplotype Hap1 (GGA). No significant associations were found between polymorphisms of INSIG2 gene and CHD. In addition, the single polymorphism analysis showed that rs9769826 of the INSIG1 gene was associated with glucose in controls. The G-allele (minor allele) carriers had higher glucose level (5.74 ± 2.03 mM) than AA genotype carriers (5.45 ± 1.37 mM,p=0.015).The present study indicated that the INSIG1 gene, but not the INSIG2 gene, was associated with CHD in the Chinese population.

Keywords

Case-control study - coronary heart disease - haplotype - INSIG1 - INSIG2

• References

• 1 Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell 2006; 124: 35-46.
• 2 Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 1999; 96: 11041-11048.
• 3 Horton JD, Shah NA, Warrington JA. et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 2003; 100: 12027-12032.
• 4 Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125-1131.
• 5 Song BL, Sever N, DeBose-Boyd RA. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell 2005; 19: 829-840.
• 6 Sever N, Song BL, Yabe D. et al. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 2003; 278: 52479-52490.
• 7 Sever N, Yang T, Brown MS. et al. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 2003; 11: 25-33.
• 8 Peng Y, Schwarz EJ, Lazar MA. et al. Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene. Genomics 1997; 43: 278-284.
• 9 Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA 2002; 99: 12753-12758.
• 10 Cervino AC, Li G, Edwards S. et al. Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics 2005; 86: 505-517.
• 11 Herbert A, Gerry NP, McQueen MB. et al. A common genetic variant is associated with adult and childhood obesity. Science 2006; 312: 279-283.
• 12 Krapivner S, Chernogubova E, Ericsson M. et al. Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia 2007; 50: 94-102.
• 13 Gabriel SB, Schaffner SF, Nguyen H. et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
• 14 Schaid DJ, Rowland CM, Tines DE. et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
• 15 Daly MJ, Rioux JD, Schaffner SF. et al. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
• 16 The International HapMap Project. Nature. 2003 426. 789-796.
• 17 Brown AJ, Sun L, Feramisco JD. et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 2002; 10: 237-245.
• 18 Radhakrishnan A, Ikeda Y, Kwon HJ. et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 2007; 104: 6511-6518.
• 19 Yang T, Espenshade PJ, Wright ME. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002; 110: 489-500.
• 20 Engelking LJ, Kuriyama H, Hammer RE. et al. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 2004; 113: 1168-1175.
• 21 Gong Y, Lee JN, Lee PC. et al. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab 2006; 03: 15-24.
• 22 Lee JN, Song B, DeBose-Boyd RA. et al. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J Biol Chem 2006; 281: 39308-39315.